Skip to main navigation
Logo - Color
  • Our Science
    • Our Science
    • Pipeline
      • Pipeline
      • RAS Pathway
      • Avutometinib (RAF/MEK Clamp)
      • Defactinib (FAK Inhibitor)
      • Avutometinib as a Backbone of Therapy
    • Clinical Trials
    • Resources
  • Investors & Media

    Investor Relations

    • Overview
    • News & Media
      • Press Releases
      • Media Resources
    • Events & Presentations
    • Corporate Governance
    • SEC Filings
    • Stock Information
    • IR Resources
  • Who We Are
    • Who We Are
    • Our Culture
    • Our Leadership
    • Join Us
  • Contact
    • General Inquiries
    • Clinical Trial Information
    • Medical Information Request
  • Patients & Caregivers

Press Releases

Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 5, 2024

Pagination

  • First page « first
  • Previous page ‹ previous
  • Page 1
  • Page 2
  • Page 3
  • Current page 4
  • Terms of Use
  • Copyright Statement
  • Privacy Policy
  • Contact
Verastem logo

© 2024 Verastem, Inc. All Rights Reserved.